R
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A63.2 KBRain Oncology Inc.Feb 14, 5:14 PM ET·0001193125-24-036584
- SC 13G/A80.0 KBRain Oncology Inc.Feb 14, 4:19 PM ET·0001104659-24-023706
- SC 13G/A103.9 KBRain Oncology Inc.Feb 7, 7:45 AM ET·0000902664-24-001173
- SC 13D/A75.4 KBRain Oncology Inc.Feb 2, 4:00 PM ET·0001214659-24-001765
- SC 13D/A301.7 KBRain Oncology Inc.Jan 29, 5:13 PM ET·0000921895-24-000154
- 8-K592.6 KBRain Oncology Inc.Jan 26, 9:26 AM ET·0001999371-24-000886
- 8-K231.7 KBRain Oncology Inc.Jan 19, 8:00 AM ET·0001839882-24-001450
- SC 13D/A138.0 KBRain Oncology Inc.Dec 19, 9:29 PM ET·0001999371-23-001092
- SC 13D/A656.4 KBRain Oncology Inc.Dec 18, 4:35 PM ET·0000921895-23-002775
- SC 13D/A299.4 KBRain Oncology Inc.Dec 18, 4:03 PM ET·0000895345-23-000680
Insiders
10- Atkisson ErikGeneral Counsel and CCO
- BERGER FRANKLIN MDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Boxer Asset Management Inc.10% Owner
- Boxer Capital, LLCDirector, 10% Owner
- Bruce JosephinePrincipal Fin. & Acc. Officer
- BRYCE RICHARD PAULChief Medical Officer
- BVF GP HOLDINGS LLCSee Explanation of Responses
- BVF I GP LLCSee Explanation of Responses
Tickers
No tickers on record
Addresses
business
8000 JARVIS AVENUE SUITE 204
NEWARK, CA, 94560
mailing
8000 JARVIS AVENUE SUITE 204
NEWARK, CA, 94560
Former Names
- Rain Therapeutics Inc.2022-12-29